🎉 Exciting news! We've added 7 exceptional researchers to NETRF's Board of Scientific Advisors. These international leaders will guide our research strategy to maximize impact for #neuroendocrinecancer patients. Learn more: https://t.co/YQEAoepstq #NETs #NECs #NENs

Congratulations to Dr. Carolin Kitzberger, recipient of the 2025 Nuclear Medicine Pilot Research Grant in #NETs ($100K). Her project, sponsored by ERF and @CureNETs will develop theranostic CAR T-cell therapy targeting SSTR2—combining imaging with personalized treatment.

Get clear, healthy-looking nails with podiatrist recommended NONYX. NONYX is clinically proven for fungus damaged and discolored, thick, brittle, yellow and lifted nails. 90% of nails improve using NONYX. So effective its money-back guaranteed.

📢 In a first-in-human Phase I/II study, the imaging tracer, 61Cu-TraceNET™, was well tolerated and produced clearer PET images with superior quality to today’s standard, finding liver & lung lesions that standard scans missed. See release: https://t.co/K1hBNb77GE #Nets

A recent study sheds new light on the prevalence of neuroendocrine cancer diagnoses in the US, with incidence increasing fivefold since 1975. Learn more on our blog. https://t.co/O0kBokC7UK #NeuroendocrineCancer #neuroendocrineneoplasms #nets #nens #NECS #CancerResearch

The NIH/NCI #Neuroendocrine Tumor (NET) SPORE is accepting letters of concept for two funding mechanisms aimed at advancing #NET research. Learn more➡️ https://t.co/Twu4H4jwef

Relax your mind and spark creativity with our 135-piece Morandi-tone cat puzzle — soft colors, artistic vibes.

Explore the latest in #pheochromocytoma & #paraganglioma research with Endocrine-Related Cancer’s special collection, featuring recent advances in genetics, metabolomics, nuclear medicine & more. Explore the collection: https://t.co/1lnW5BH3AW

Dr. Benjamin Viglianti, 2023 NETRF Investigator Award recipient, published a new study on molecular imaging advances for #neuroendocrineneoplasms that are enabling more precise diagnoses and better treatment planning for patients. Read more: https://t.co/iISKI4AQCB

Congratulations to @SuzannDuan on winning the 2025 BTSI Award! Her research on the epigenetic landscape of GEP-NETs shows great promise for #neuroendocrinecancer diagnosis and care. Learn more: https://t.co/hAlB24SI0Z

Be a part of @EndoOncology's special collection celebrating the contributions and leadership of women in Neuroendocrine Tumour (NET) research. Original research, reviews and case reports are all welcome!🔗 https://t.co/VzOxY9sRa5 Submit your proposal: eo@bioscientifica.com

Did you know? Rio Grande LNG has made ~$950,000 in charitable donations focused on community development and supporting 60+ local organizations.

Sponsored by NETRF, this $100,000 grant is designed to help an early-career, basic or clinical scientist conduct novel and innovative #NETs research. Learn more: https://t.co/nIbXyAcQ3e #neuroendocrinecancer #earlycareerresearcher

📣Happening now! #KNOWYOURNETs2025 LIVE question & answer session! Ask your question on https://t.co/E9QEPJxSiR and watch #neuroendocrinecancer experts. It's all right here: https://t.co/R4MW5FYqf4 #research #NETs #NECs #thrivership #treatment

See #neuroendocrinecancer experts in our #KNOWYOURNETs2025 LIVE Q&A session. Starts at 3:10PM ET. Ask your questions now at https://t.co/R4MW5FYqf4 #cancerresearch #thrivership #NETs #NECs

Listen in on a #neuroendocrinecancer Tumor Board, next on #KNOWYOURNETs2025. A Tumor Board is an essential part of a multi-disciplinary #NET and #NEC program and guides treatment. Learn more! https://t.co/R4MW5FXSpw

The one gift that never misses 🎁 Bartesian is made for every home and every celebration.

Up next on #KNOWYOURNETs2025: Unusual #NETs with Dr. Jaydira del Rivero. Join us! https://t.co/R4MW5FXSpw

#KNOWYOURNETs2025 is going on now! Plan to watch our LIVE Question & Answer session at 3:10 PM ET. Tune in here: https://t.co/R4MW5FXSpw

Up next on #KNOWYOURNETs2025 treatment sequencing for liver metastases and advanced #NETs. You can join us at https://t.co/R4MW5FYqf4 #neuroendocrinecancer #thrivership #NECs

#KNOWYOURNETs2025 is LIVE NOW! Join the conference to learn about the latest #neuroendocrinecancer research, treatment and thrivership. https://t.co/R4MW5FYqf4

I think this might be the first time we have Open Source at the majority of the top 5,000 sites, which is a big win.

Submit questions for Know Your NETs, our largest patient/caregiver conference tomorrow! Use https://t.co/E9QEPJxktj with code "NETRF" to ask anonymously. Not registered? Join us online at 11 AM ET: https://t.co/0AOZpIAK7Y #neuoendocrinecancer #NETs #NECs #cancerresearch

NETRF's Know Your NETs virtual conference is THE event for neuroendocrine cancer patients & caregivers. Get the latest treatment insights, connect with experts, and connect with our amazing community — free and online. Sign up before registration closes. https://t.co/0AOZpIBhXw

Neuroendocrine cancer research is steadily moving forward, with new clinical trials exploring innovative, targeted approaches to treatment. Learn more about current trials https://t.co/wsnQtCaclw #NETS #NeuroendocrineCancer #NeuroendocrineTumor #NECS #cancerresearch